CN111643501A
|
|
Use of Gensci073 or analogues thereof
|
CN111518206A
|
|
Humanized anti-Abeta monoclonal antibody and application thereof
|
CN111518205A
|
|
Humanized anti-Abeta monoclonal antibody and application thereof
|
CN111518207A
|
|
Humanized anti-Abeta monoclonal antibody and application thereof
|
CN111378044A
|
|
Antibody fusion protein, preparation method and application thereof
|
CN111378045A
|
|
Bivalent and bispecific antibody, preparation method thereof, encoding gene, host cell and composition
|
CN110872348A
|
|
Humanized anti-CD 47 monoclonal antibody and application thereof
|
CN107198677A
|
|
Progesterone suspension type long-acting injection and preparation method thereof and progesterone, which are suspended, injects powder pin
|
CN107157956A
|
|
Matrix type progesterone sustained-release micro-spheres and preparation method thereof and progesterone are slow-release injected
|
CN107157957A
|
|
Progesterone sustained-release micro-spheres and nanoparticle, its preparation method and progesterone are slow-release injected
|
CN106928354A
|
|
The β monoclonal antibodies of anti-IL 1 and its application
|
CN106892980A
|
|
Anti-vegf R2 monoclonal antibodies and its application
|
CN106084052A
|
|
Anti-CD47 monoclonal antibody and application thereof
|
CN105801684A
|
|
Recombinant human growth hormone and application thereof in promoting follicular development
|
CN105859869A
|
|
Granulocyte macrophage stimulating factor, and preparation and application thereof
|
CN105461808A
|
|
Monoclonal antibody and application thereof
|
CN103030691A
|
|
Method for separating and purifying gonadotropin glycoprotein subunits
|
CN102295695B
|
|
Recombinant human follicle stimulating hormone and preparation thereof
|
CN102389756A
|
|
Method for preparing micro spheres by multiple emulsion process
|